N-[3-[(2R,5S,8S,14R)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxy-3-iodophenyl)methyl]-1-methyl-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]-N'-(8-methyl-3,6,10,13,16,19-hexazabicyclo[6.6.6]icosan-1-yl)pentanediamide

C56H85IN16O8 — CID 167337697

IUPACN-[3-[(2R,5S,8S,14R)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxy-3-iodophenyl)methyl]-1-methyl-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]-N'-(8-methyl-3,6,10,13,16,19-hexazabicyclo[6.6.6]icosan-1-yl)pentanediamide
SMILESCN1C(=O)[C@@H](Cc2ccc(O)c(I)c2)NC(=O)CNC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1CCCNC(=O)CCCC(=O)NC12CNCCNCC(C)(CNCCNC1)CNCCNC2
InChIInChI=1S/C56H85IN16O8/c1-55-31-60-20-23-63-34-56(35-64-24-21-61-32-55,36-65-25-22-62-33-55)72-48(76)13-5-12-47(75)66-18-7-11-45-52(80)70-42(10-6-19-67-54(58)59)51(79)71-43(28-37-14-16-39-8-3-4-9-40(39)26-37)50(78)68-30-49(77)69-44(53(81)73(45)2)29-38-15-17-46(74)41(57)27-38/h3-4,8-9,14-17,26-27,42-45,60-65,74H,5-7,10-13,18-25,28-36H2,1-2H3,(H,66,75)(H,68,78)(H,69,77)(H,70,80)(H,71,79)(H,72,76)(H4,58,59,67)/t42-,43-,44+,45+,55?,56?/m0/s1
InChIKeyDOVPZQITSSDOGQ-ATOZTZHASA-N
MW1237.30 g/mol
LogP-2.11
Rot. Bonds17

About N-[3-[(2R,5S,8S,14R)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxy-3-iodophenyl)methyl]-1-methyl-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]-N'-(8-methyl-3,6,10,13,16,19-hexazabicyclo[6.6.6]icosan-1-yl)pentanediamide

N-[3-[(2R,5S,8S,14R)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxy-3-iodophenyl)methyl]-1-methyl-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]-N'-(8-methyl-3,6,10,13,16,19-hexazabicyclo[6.6.6]icosan-1-yl)pentanediamide (PubChem CID 167337697) has the molecular formula C56H85IN16O8 and a molecular weight of 1237.30 g/mol. Its IUPAC name is N-[3-[(2R,5S,8S,14R)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxy-3-iodophenyl)methyl]-1-methyl-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]-N'-(8-methyl-3,6,10,13,16,19-hexazabicyclo[6.6.6]icosan-1-yl)pentanediamide.

Molecular Properties

Compound NameN-[3-[(2R,5S,8S,14R)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxy-3-iodophenyl)methyl]-1-methyl-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]-N'-(8-methyl-3,6,10,13,16,19-hexazabicyclo[6.6.6]icosan-1-yl)pentanediamide
PubChem CID167337697
Molecular FormulaC56H85IN16O8
Molecular Weight1237.30 g/mol
Exact Mass1236.58
IUPAC NameN-[3-[(2R,5S,8S,14R)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxy-3-iodophenyl)methyl]-1-methyl-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]-N'-(8-methyl-3,6,10,13,16,19-hexazabicyclo[6.6.6]icosan-1-yl)pentanediamide
SMILESCN1C(=O)[C@@H](Cc2ccc(O)c(I)c2)NC(=O)CNC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1CCCNC(=O)CCCC(=O)NC12CNCCNCC(C)(CNCCNC1)CNCCNC2
InChIInChI=1S/C56H85IN16O8/c1-55-31-60-20-23-63-34-56(35-64-24-21-61-32-55,36-65-25-22-62-33-55)72-48(76)13-5-12-47(75)66-18-7-11-45-52(80)70-42(10-6-19-67-54(58)59)51(79)71-43(28-37-14-16-39-8-3-4-9-40(39)26-37)50(78)68-30-49(77)69-44(53(81)73(45)2)29-38-15-17-46(74)41(57)27-38/h3-4,8-9,14-17,26-27,42-45,60-65,74H,5-7,10-13,18-25,28-36H2,1-2H3,(H,66,75)(H,68,78)(H,69,77)(H,70,80)(H,71,79)(H,72,76)(H4,58,59,67)/t42-,43-,44+,45+,55?,56?/m0/s1
InChIKeyDOVPZQITSSDOGQ-ATOZTZHASA-N
XLogP-2.11
TPSA351.72 Ų
H-Bond Donors15
H-Bond Acceptors15
Rotatable Bonds17
Heavy Atoms81
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001237.30
LogP ≤ 5-2.11
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}

Analyze N-[3-[(2R,5S,8S,14R)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxy-3-iodophenyl)methyl]-1-methyl-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]-N'-(8-methyl-3,6,10,13,16,19-hexazabicyclo[6.6.6]icosan-1-yl)pentanediamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[(2R,5S,8S,14R)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxy-3-iodophenyl)methyl]-1-methyl-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]-N'-(8-methyl-3,6,10,13,16,19-hexazabicyclo[6.6.6]icosan-1-yl)pentanediamide?
The IUPAC name of N-[3-[(2R,5S,8S,14R)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxy-3-iodophenyl)methyl]-1-methyl-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]-N'-(8-methyl-3,6,10,13,16,19-hexazabicyclo[6.6.6]icosan-1-yl)pentanediamide (CID 167337697) is N-[3-[(2R,5S,8S,14R)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxy-3-iodophenyl)methyl]-1-methyl-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]-N'-(8-methyl-3,6,10,13,16,19-hexazabicyclo[6.6.6]icosan-1-yl)pentanediamide.
What is the SMILES notation for N-[3-[(2R,5S,8S,14R)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxy-3-iodophenyl)methyl]-1-methyl-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]-N'-(8-methyl-3,6,10,13,16,19-hexazabicyclo[6.6.6]icosan-1-yl)pentanediamide?
The canonical SMILES for N-[3-[(2R,5S,8S,14R)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxy-3-iodophenyl)methyl]-1-methyl-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]-N'-(8-methyl-3,6,10,13,16,19-hexazabicyclo[6.6.6]icosan-1-yl)pentanediamide is CN1C(=O)[C@@H](Cc2ccc(O)c(I)c2)NC(=O)CNC(=O)[C@H](Cc2ccc3ccccc3c2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1CCCNC(=O)CCCC(=O)NC12CNCCNCC(C)(CNCCNC1)CNCCNC2.
What is the InChIKey of N-[3-[(2R,5S,8S,14R)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxy-3-iodophenyl)methyl]-1-methyl-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]-N'-(8-methyl-3,6,10,13,16,19-hexazabicyclo[6.6.6]icosan-1-yl)pentanediamide?
The InChIKey is DOVPZQITSSDOGQ-ATOZTZHASA-N. The full InChI is InChI=1S/C56H85IN16O8/c1-55-31-60-20-23-63-34-56(35-64-24-21-61-32-55,36-65-25-22-62-33-55)72-48(76)13-5-12-47(75)66-18-7-11-45-52(80)70-42(10-6-19-67-54(58)59)51(79)71-43(28-37-14-16-39-8-3-4-9-40(39)26-37)50(78)68-30-49(77)69-44(53(81)73(45)2)29-38-15-17-46(74)41(57)27-38/h3-4,8-9,14-17,26-27,42-45,60-65,74H,5-7,10-13,18-25,28-36H2,1-2H3,(H,66,75)(H,68,78)(H,69,77)(H,70,80)(H,71,79)(H,72,76)(H4,58,59,67)/t42-,43-,44+,45+,55?,56?/m0/s1.
What are the key properties of N-[3-[(2R,5S,8S,14R)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxy-3-iodophenyl)methyl]-1-methyl-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]-N'-(8-methyl-3,6,10,13,16,19-hexazabicyclo[6.6.6]icosan-1-yl)pentanediamide?
N-[3-[(2R,5S,8S,14R)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxy-3-iodophenyl)methyl]-1-methyl-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]-N'-(8-methyl-3,6,10,13,16,19-hexazabicyclo[6.6.6]icosan-1-yl)pentanediamide has a molecular weight of 1237.30 g/mol, XLogP of -2.11, 17 rotatable bonds, 15 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[(2R,5S,8S,14R)-5-[3-(diaminomethylideneamino)propyl]-14-[(4-hydroxy-3-iodophenyl)methyl]-1-methyl-8-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]-N'-(8-methyl-3,6,10,13,16,19-hexazabicyclo[6.6.6]icosan-1-yl)pentanediamide is sourced from PubChem (CID 167337697), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).